Safety and Efficacy of Sofosbuvir Plus Velpatasvir With or Without Ribavirin in Treatment-experienced Subjects With Chronic HCV Infection

NCT01909804 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

323

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: SOF
DRUG: VEL
DRUG: RBV

Sponsor

Gilead Sciences